2013, Seattle

Responsive image


ARVO/Alcon Keynote Series  

"Global Burden of Disease Study 2010: Key Findings and Implications for Vision Research"

Christopher Murray, MD, DPhil

The Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) is a systematic, scientific effort to quantify the comparative magnitude of health loss due to diseases, injuries and risk factors by age, sex and geography for specific points in time. Drawing on the efforts of a multitude of people, including almost 500 co-authors around the world, the study represents the largest review of epidemiological data sources relevant to burden of disease.

ARVO/Champalimaud Award lecture

The 2012 António Champalimaud Vision Award, worth a total of €1 million recognizes the development of two novel approaches to visualizing the living human retina in health and disease: Optical coherence tomography (OCT) and adaptive optics technologies (AO).

Results from the Age-Related Eye Disease Study 2 (AREDS2) from the National Eye Institute

Findings from a randomized, controlled clinical trial of lutein/zeaxanthin and omega-3 fatty acids for the treatment of age-related macular degeneration and cataract.